Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2015 | 1 |
2017 | 1 |
2018 | 1 |
2019 | 1 |
2020 | 3 |
2024 | 0 |
Search Results
6 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Combined C-Reactive Protein and Novel Inflammatory Parameters as a Predictor in Cancer-What Can We Learn from the Hematological Experience?
Cancers (Basel). 2020 Jul 19;12(7):1966. doi: 10.3390/cancers12071966.
Cancers (Basel). 2020.
PMID: 32707721
Free PMC article.
Review.
The Biological Context of C-Reactive Protein as a Prognostic Marker in Renal Cell Carcinoma: Studies on the Acute Phase Cytokine Profile.
Aarstad HH, Guðbrandsdottir G, Hjelle KM, Bostad L, Bruserud Ø, Tvedt THA, Beisland C.
Aarstad HH, et al.
Cancers (Basel). 2020 Jul 19;12(7):1961. doi: 10.3390/cancers12071961.
Cancers (Basel). 2020.
PMID: 32707675
Free PMC article.
Item in Clipboard
The Acute Phase Reaction and Its Prognostic Impact in Patients with Head and Neck Squamous Cell Carcinoma: Single Biomarkers Including C-Reactive Protein Versus Biomarker Profiles.
Aarstad HH, Moe SEE, Bruserud Ø, Lybak S, Aarstad HJ, Tvedt THA.
Aarstad HH, et al.
Biomedicines. 2020 Oct 14;8(10):418. doi: 10.3390/biomedicines8100418.
Biomedicines. 2020.
PMID: 33066437
Free PMC article.
Item in Clipboard
EORTC Quality of Life Questionnaire Head and Neck (H&N)-35 scores from H&N squamous cell carcinoma patients obtained at diagnosis and at 6, 9 and 12 months following diagnosis predict 10-year overall survival.
Aarstad HJ, Østhus AA, Aarstad HH, Lybak S, Aarstad AKH.
Aarstad HJ, et al. Among authors: aarstad hh.
Eur Arch Otorhinolaryngol. 2019 Dec;276(12):3495-3505. doi: 10.1007/s00405-019-05630-2. Epub 2019 Sep 16.
Eur Arch Otorhinolaryngol. 2019.
PMID: 31529149
Item in Clipboard
General health-related quality of life scores from head and neck squamous cell carcinoma patients obtained throughout the first year following diagnosis predicted up to 10-year overall survival.
Aarstad HJ, Østhus AA, Aarstad HH, Lybak S, Aarstad AKH.
Aarstad HJ, et al. Among authors: aarstad hh.
Eur Arch Otorhinolaryngol. 2018 Jan;275(1):207-217. doi: 10.1007/s00405-017-4800-8. Epub 2017 Nov 20.
Eur Arch Otorhinolaryngol. 2018.
PMID: 29159750
Item in Clipboard
In Vitro-Stimulated IL-6 Monocyte Secretion and In Vivo Peripheral Blood T Lymphocyte Activation Uniquely Predicted 15-Year Survival in Patients with Head and Neck Squamous Cell Carcinoma.
Aarstad HH, Vintermyr OK, Ulvestad E, Kross K, Heimdal JH, Aarstad HJ.
Aarstad HH, et al.
PLoS One. 2015 Jun 16;10(6):e0129724. doi: 10.1371/journal.pone.0129724. eCollection 2015.
PLoS One. 2015.
PMID: 26079381
Free PMC article.
Item in Clipboard
Cite
Cite